Celestia (TIA) is trading at $0.486051, down 2.23% over 24 hours. The decline contrasts with gains of 10.18% over seven days and 29.32% over 30 days, leaving the near-term direction weaker than the broader recent trend.

The price is above its hourly 8, 13, 21, and 144 moving averages, which range from $0.4753 to $0.4849. It is slightly below the 55-hour average of $0.4867, so the moving-average picture is mostly positive but does not show strength across every measured interval.

The one-hour RSI of 68 indicates elevated short-term momentum, nearing—but not reaching—the conventional overbought threshold of 70. The seven-day RSI of 51 is more neutral, tempering the short-term reading rather than confirming broadly overheated conditions.

Momentum across the supplied periods is mixed: the seven-day gain is strong, while the 14-day change is nearly flat at 0.20%. Together with the positive 30-day return, this suggests the broader monthly advance has not translated into consistent gains across every shorter window.

TIA’s 24-hour range was $0.462856 to $0.500214, and the current price sits between those extremes, below the high despite the recent weekly rise. The 24-hour volume of 78.1 million and volume-to-market-cap ratio of 16.41% provide activity context, but without comparative volume data they do not establish whether buying or selling pressure is increasing.

At $0.486051, TIA remains about 97.7% below its $20.85 all-time high from February 10, 2024. That is substantial historical depreciation, but the supplied data do not establish why it occurred or whether it predicts future performance.

The main bullish evidence is the positive seven- and 30-day performance and price above four of the five hourly moving averages. The main bearish evidence is the 24-hour decline, the slight shortfall below the 55-hour average, and an elevated one-hour RSI that leaves limited room for a clear short-term momentum signal.

The overall rating is Hold: recent performance and most hourly averages support resilience, but the mixed 14-day return and current daily loss make the advance less consistent. The primary evidence for holding rather than buying or selling is the balance between positive weekly and monthly momentum on one side, and near-term weakness plus incomplete moving-average confirmation on the other.